Pfizer - 50 Year Stock Price History | PFE

Historical daily share price chart and data for Pfizer since 1972 adjusted for splits. The latest closing stock price for Pfizer as of August 08, 2022 is 49.57.
  • The all-time high Pfizer stock closing price was 61.25 on December 16, 2021.
  • The Pfizer 52-week high stock price is 61.71, which is 24.5% above the current share price.
  • The Pfizer 52-week low stock price is 40.94, which is 17.4% below the current share price.
  • The average Pfizer stock price for the last 52 weeks is 50.16.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Pfizer Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2022 51.4063 56.6500 56.6900 45.7500 49.5700 -16.05%
2021 42.1506 36.8100 61.2500 33.4900 59.0500 60.42%
2020 36.5741 39.1400 42.5600 28.4900 36.8100 -6.05%
2019 39.9501 43.2500 44.4000 34.2400 39.1800 -10.24%
2018 39.1565 36.4400 46.2300 33.6300 43.6500 20.51%
2017 34.0745 33.0000 37.2000 31.1500 36.2200 11.51%
2016 32.8259 31.9500 37.3100 28.5600 32.4800 0.62%
2015 33.7029 31.3300 36.1500 30.8200 32.2800 3.63%
2014 30.3074 30.4600 32.7500 27.7000 31.1500 1.70%
2013 28.9784 25.9100 32.2000 25.8500 30.6300 22.13%
2012 23.1972 21.9700 26.0350 20.9500 25.0793 15.89%
2011 19.5250 17.6800 21.8300 16.6600 21.6400 23.59%
2010 16.7635 18.9300 20.0000 14.1400 17.5100 -3.74%
2009 15.7289 18.2700 18.8500 11.6600 18.1900 2.71%
2008 19.3092 22.9100 24.0800 14.4500 17.7100 -22.09%
2007 25.2537 26.2900 27.6800 22.3000 22.7300 -12.24%
2006 25.6807 23.7800 28.4700 22.4100 25.9000 11.06%
2005 25.5458 26.4500 28.9000 20.6000 23.3200 -13.28%
2004 32.9606 35.5500 38.8500 24.2900 26.8900 -23.89%
2003 31.8957 31.5300 36.1800 28.5600 35.3300 15.57%
2002 34.8486 39.9000 42.1500 25.9200 30.5700 -23.29%
2001 41.6901 46.1300 46.1300 35.6700 39.8500 -13.37%
2000 41.5348 31.8800 49.0000 30.0000 46.0000 41.80%
1999 38.5371 41.1667 50.0333 31.7100 32.4400 -22.14%
1998 34.0287 25.2300 42.0333 24.6467 41.6667 67.65%
1997 18.7476 13.6467 25.9367 13.6467 24.8533 79.66%
1996 12.1970 10.3750 15.0833 10.1250 13.8333 31.75%
1995 8.0450 6.3333 11.0417 6.2183 10.5000 63.11%
1994 5.4321 5.6667 6.5517 4.4683 6.4375 11.96%
1993 5.3479 6.0317 6.2292 4.5000 5.7500 -4.83%
1992 6.2440 7.0000 7.1458 5.5417 6.0417 -13.69%
1991 4.9433 3.3383 7.1458 3.1096 7.0000 108.05%
1990 2.8506 2.9583 3.3958 2.3333 3.3646 16.19%
1989 2.6167 2.4063 3.1146 2.2554 2.8958 19.82%
1988 2.2403 2.0258 2.5054 2.0258 2.4167 24.39%
1987 2.7350 2.5833 3.1875 1.7346 1.9429 -23.56%
1986 2.5109 2.0833 3.0313 1.9583 2.5417 20.48%
1985 1.9264 1.6821 2.3229 1.5883 2.1096 19.84%
1984 1.4867 1.5054 1.7604 1.2500 1.7604 18.18%
1983 1.6057 1.4115 1.8646 1.4115 1.4896 3.80%
1982 1.2589 1.0938 1.6615 1.0469 1.4350 29.35%
1981 1.0252 1.1094 1.1406 0.8490 1.1094 0.00%
1980 0.8654 0.7813 1.1094 0.6798 1.1094 35.26%
1979 0.6948 0.6900 0.8490 0.6094 0.8202 18.87%
1978 0.6617 0.5702 0.7996 0.5313 0.6900 21.01%
1977 0.5568 0.5990 0.5990 0.4896 0.5702 -6.43%
1976 0.5883 0.5913 0.6510 0.5313 0.6094 4.92%
1975 0.6224 0.6692 0.7604 0.5000 0.5808 -14.56%
1974 0.6908 0.9010 0.9192 0.4504 0.6798 -24.55%
1973 0.9142 0.9088 1.0913 0.8100 0.9010 0.86%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $276.449B $81.288B
Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. Pfizer spinned-off its Upjohn unit, its off-patent branded and generic established medicines business, and combined it with generic drugmaker Mylan to create a new generic pharmaceutical company called Viatris. The Consumer Healthcare (CHC) segment, an over-the-counter (OTC) medicines business, was merged with Glaxo's unit to form a new joint venture.?The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $449.879B 17.13
Eli Lilly (LLY) United States $286.307B 36.30
AbbVie (ABBV) United States $244.068B 10.37
Novo Nordisk (NVO) Denmark $233.538B 30.81
Merck (MRK) United States $221.043B 11.56
Novartis AG (NVS) Switzerland $189.332B 13.96